Yeyan Zhang
Keine laufenden Positionen mehr
Profil
Yeyan Zhang is President of Dynal Biotech Ltd.
He was a Director of Welichem Biotech, Inc. until October 6, 2008.
Dr. Zhang received a BS from Huazhong Agricultural University, an MBA from the University of Chicago and a PhD from Simon Fraser University.
Ehemalige bekannte Positionen von Yeyan Zhang
Unternehmen | Position | Ende |
---|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Direktor/Vorstandsmitglied | 06.10.2008 |
Ausbildung von Yeyan Zhang
Simon Fraser University | Doctorate Degree |
The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |